TickerFactsScreenerDevelopers

Axsome Therapeutics, Inc. (AXSM) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $20.2K2016: $104.6K2017: $9.9K2018: $32.7K2019: $16.1K2020: $45.9K2021: $308.0K2022: $702.0K2023: $582.0K2024: $270.0K2025: $480.0K$480.0K
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$480.0K+77.8%
2024$270.0K-53.6%
2023$582.0K-17.1%
2022$702.0K+127.9%
2021$308.0K+571.2%
2020$45.9K+184.7%
2019$16.1K-50.7%
2018$32.7K+230.3%
2017$9.9K-90.5%
2016$104.6K+417.8%
2015$20.2K—